NetworkNewsBreaks Archive - Page 1177 of 2081

TuesdayJan 19, 2021 8:30 am

NetworkNewsBreaks – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRA: 2TP2) Menthol Product Sells Out During First Weeks of Availability

TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRA: 2TP2) announced that its flagship product — TAAT(TM) Menthol — sold out within weeks of being released for retail sale to legal-aged smokers in Ohio. TAAT released three offerings of its TAAT product: Menthol, Smooth and Original; Menthol sold out and was the first to be reordered by tobacco retailers throughout the state. Before launching its product line in the United States, TAAT announced its strategic plan to focus on the menthol cigarette space; in that announcement, the company noted that the market for menthol cigarettes is approximately $80 billion…

FridayJan 15, 2021 1:10 pm

NetworkNewsBreaks – Innovative Payment Solutions Inc. (IPSI) Eyes Opportunity in Unbanked, Underbanked Communities

Innovative Payment Solutions (OTCQB: IPSI) is a digital payment technology service company that provides cutting-edge solutions for consumers and service providers. As the global pandemic has fueled the development and acceptance of digital technologies that offer the security and stability the world is looking for right now, Blockchain seems particularly well suited for this time and place. “Because blockchain technologies are uniquely suited to verifying, securing and sharing data, they’re ideal for managing multi-party, inter-organizational, and cross-border transactions,” a recent Harvard Business Review article observes (https://nnw.fm/k1lmo). Titled “How the Pandemic Is Pushing Blockchain Forward,” the article notes that “over the past…

FridayJan 15, 2021 11:56 am

NetworkNewsBreaks – PDS Biotechnology Corporation (NASDAQ: PDSB) Releases White Paper Detailing the Potential of the Versamune(R) Platform

PDS Biotechnology (NASDAQ: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the company’s proprietary Versamune(R) T-cell activating technology, on Thursday released a white paper detailing how the Versamune(R) platform works to treat cancer, and the potential of Versamune(R) in the treatment of a broad range of cancers. The current PDS Biotech pipeline of Versamune(R)-based therapies focuses on four key antigens associated with a broad variety of solid tumors that remain challenging to treat. According to PDS Biotech CEO, Dr. Frank Bedu-Addo, "We are currently pursuing an ambitious development strategy, working with leading oncology…

FridayJan 15, 2021 11:18 am

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Present at NobleCon17

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and critical minerals in the United States, is pleased to announce that the company's president and CEO Mark S. Chalmers will present at NobleCon17 – Noble Capital Markets' Seventeenth Annual Investor Conference on Tuesday, Jan. 19, 2021 at 10:30 a.m. ET. According to the update, the conference is virtual, with no cost, obligation or restrictions to attend. Chalmers will provide an update on Energy Fuels' various uranium and critical mineral initiatives, with particular emphasis on the company's progress on producing rare earth elements. A high-definition, video webcast of…

FridayJan 15, 2021 10:42 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Partnership with Cosmetic Brand Nootka & Sea

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) is pleased to announce it has entered into a strategic partnership with Nootka & Sea, a privately held British Columbia company that carries on the business of apothecary and cosmetics. According to the update, the addition allows PlantX to further expand its category verticals. "We are aiming to be the digital face of the plant-based community, and as such we want to be able to carry and offer the very highest-quality products for our customers," said Sean Dollinger, PlantX founder. "This partnership will help us capitalize on this exciting market." To…

FridayJan 15, 2021 9:47 am

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Featured in Pharma Mirror Magazine Article

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, was featured in a recent article published by Pharma Mirror Magazine. The article titled, “Neurology’s Growing Need for Disposable Technologies,” is written by Brain Scientific’s co-founder and executive chairman. The piece indicates that several studies have recently shown that the development of neurological conditions and symptoms are prevalent in COVID patients. “When conditions like seizures, stroke and metabolic encephalopathy emerge, suddenly in a COVID-19 patient, it can negatively impact treatment outcomes and morbidity rates,” the article reads. “Facing evidence that these symptoms are common in COVID patients at all…

FridayJan 15, 2021 9:16 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Enhances Software to Reduce Frustration, Ensure Smooth Transactions

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), an innovative automotive fintech leader providing digital and virtual platform solutions, on Thursday announced it has added specialized platform enhancing software to its suite of offerings. The newly procured software is designed to reduce consumer frustration when performing complex transactions online. Over the past six months, the company has augmented the code into the DrivrZ platform in accordance with an agreement to pay $200,000 upon completion. “Today's online customer wants simplicity, transparency and convenience in a seamless transaction. We have all experienced the frustration of being unable complete an online transaction after…

ThursdayJan 14, 2021 2:52 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Appoints Chris Ford to GOH’s Advisory Board for Chilean Operations

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced the appointment of Chris Ford to the company's advisory board for its Chilean operations. Ford will be joining the company’s head of exploration, Pat Burns, who discovered Escondida (one of the top two Copper mines in the world), and Jack Pritting, who was instrumental in leading the exploration of Kinross's La Coipa mine (6.2 Million ounces of Gold). "Chris led the Gold Fields team that discovered the Salares Norte epithermal silver and gold deposit (5.2 Million…

ThursdayJan 14, 2021 2:18 pm

NetworkNewsBreaks – Kaival Brands Innovations Group Inc.’s (KAVL) Bidi Stick No. 1 Electronic Nicotine Delivery System Offering, Sees Market Growth of Over 900%

Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, announced that Bidi Vapor's primary offering, the Bidi(r) Stick, is the fastest-growing closed system vaping product in the country; KAVL is the exclusive global distributor of products manufactured by Bidi Vapor. KAVL reported that the Bidi Stick has seen market growth of 907.9% year over year for Q4 2020, making it the No. 1 disposable electronic nicotine delivery system ("ENDS") offering in the United States for the quarter and resulting in 27.9% market share in calendar fourth…

ThursdayJan 14, 2021 1:00 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present at NobleCon17

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has announced that it will present at the upcoming NobleCon17, scheduled for Jan. 19–20, 2021. The virtual event is Noble Capital Markets’ annual investor conference. GNPX’s presentation will include a company overview and address the company’s recent progress on planned clinical trials focusing on the treatment of non-small cell lung cancer. Genprex president and CEO Rodney Varner will deliver the presentation to participating investors. The Genprex presentation is scheduled for Tuesday, Jan. 19, at 3:45 p.m. EST. A replay of the presentation…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks